These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1792777)

  • 1. [Changes in the clinical and immunological indices of patients with disseminated sclerosis being treated with prednisolone].
    Iarosh AA; Tiazhkorob AM; Prokopiv MM; Kanevskaia SA; Zhovnir IK
    Vrach Delo; 1991 Dec; (12):61-3. PubMed ID: 1792777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of prednisolone on the immunoglobulin content of the blood in patients with disseminated sclerosis].
    Iarosh AA; Prokopiv MM; Zhovnir IK; Kanevskaia SA
    Vrach Delo; 1990 Aug; (8):70-2. PubMed ID: 2256298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the immunological reactivity of patients with disseminated sclerosis treated by prednisolone and the preparation Proper-Myl].
    Iarosh AA; Macheret EL; Iarosh AA; Zapadniuk BV
    Vrach Delo; 1990 Feb; (2):83-6. PubMed ID: 2339565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The dynamics of immunological indicators in the treatment of patients with multiple sclerosis with prednisolone combined with plasmapheresis].
    Neretin VIa; Gannushkina IV; Zhirnova IG; Sapfirova VA; Kir'iakov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):17-21. PubMed ID: 3259769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corticosteroid therapy of multiple sclerosis with attention to biorhythms].
    Lobzin VS; Bagdasarova IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):190-4. PubMed ID: 3518312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B; Sørensen PS
    Ugeskr Laeger; 1994 Oct; 156(43):6353-8. PubMed ID: 7810008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of glucocorticoid hormones in multiple sclerosis].
    Leonovich AL; Gitkina LS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1318-22. PubMed ID: 1015135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial experiences with the Reiber 1979 determination of autochthonous IgG production within the scope of clinical and immunologic follow-up studies in multiple sclerosis treated with immunosuppressive therapy].
    Dachsel R; Köppel C
    Psychiatr Neurol Med Psychol (Leipz); 1989 Jul; 41(7):420-5. PubMed ID: 2772076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenetic therapy of nervous system and muscular diseases using large doses of prednisolone on alternate days].
    Gekht BM; Kuzin MI; Kolomenskaia EA; Gnezditskaia EV; Zefirova GS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(3):286-90. PubMed ID: 220823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
    Zapadniuk BV; Kravets AS; Iarosh AA; Shurinok LA
    Vrach Delo; 1988 Aug; (8):84-6. PubMed ID: 3206892
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-immunologic parallels in evaluating the treatment of multiple sclerosis].
    Chernigovskaia NV; Ogurtsov RP; Matveeva TS; Popov VG; Puzyreva VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):24-8. PubMed ID: 2160163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thymectomy in disseminated sclerosis].
    Veĭn AM; Khomak VIa; Belokrinitskiĭ DV; Shkrob OS; Golubkov VA
    Sov Med; 1981; (12):42-5. PubMed ID: 6977873
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple sclerosis immune complexes: an analysis of component antigens and antibodies.
    Coyle PK; Procyk-Dougherty Z
    Ann Neurol; 1984 Dec; 16(6):660-7. PubMed ID: 6098217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with intrathecal glucocorticoid therapy in inflammatory neurological diseases (35 case reports)].
    Göpel W; Bertram W
    Z Arztl Fortbild (Jena); 1971 Jan; 65(2):99-103. PubMed ID: 5109213
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
    Neretin VIa; Kir'iakov VA; Sapfirova VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):119-26. PubMed ID: 2160156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Folic acid in the combined treatment of patients with disseminated sclerosis and chronic gastritis].
    Kanevskaia SA; Kravets AS; Slesarenko EV; Shevchenko VI; Tkachenko NV
    Vrach Delo; 1990 Apr; (4):96-7. PubMed ID: 2275187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological complications in multiple sclerosis patients receiving interferon.
    Rice GP; Woelfel EL; Talbot PJ; Braheny SL; Sipe JC; Knobler RL; Merigan TC; Oldstone MB
    Ann Neurol; 1985 Oct; 18(4):439-42. PubMed ID: 2416266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences with intrathecal corticosteroid treatment of polysclerosis and other neurological diseases].
    Schmidt E
    Psychiatr Neurol Med Psychol (Leipz); 1967 Apr; 19(4):152-6. PubMed ID: 6072684
    [No Abstract]   [Full Text] [Related]  

  • 19. [Corticosteroid therapy of disseminated sclerosis].
    Lobzin VS; Bardasarova IA; Golovkin VI
    Sov Med; 1985; (9):105-9. PubMed ID: 3906928
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of prednisolone-dependent form of multiple sclerosis].
    Neretin VIa; Lobov MA; Kotov SV; Safronova OG
    Sov Med; 1991; (4):64-5. PubMed ID: 1871637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.